See All Slides - tctmd.com

Slides

Presentation TVT 2019

Acute Kidney Injury After Transcatheter Aortic Valve Replacement Is a Strong Predictor of Intermediate but Not Long-Term Mortality: Observations From Michigan Transcatheter Aortic Valve Replacement (MITAVR) Registry

Presenter: Sarah Gualano

June 13, 2019

Presentation TVT 2019

Feasibility of Repeat Transcatheter Aortic Valve Replacement (TAVR) After Sapien 3 TAVR (TAV-in-TAV): A Pilot Angiographic Study

Presenter: Gilbert Tang

June 13, 2019

Presentation TVT 2019

Diabetes Mellitus: Is There a True Paradoxical Clinical Outcome After AVR?

Presenter: Rashad Belin

June 13, 2019

Presentation TVT 2019

Transcatheter Aortic Valve-in-Valve in Patients With Previous Homograft

Presenter: Karim Al-Azizi

June 13, 2019

Presentation TVT 2019

Outcomes of Transcatheter Aortic Valve Replacement (TAVR) for Mixed Aortic Valve Disease: Results From the TVT Registry

Presenter: Bhaskar Bhardwaj

June 13, 2019

Presentation TVT 2019

Rationalizing the Cost Effectiveness of Cerebral Protection During TAVR

Presenter: Hemal Gada

June 13, 2019

Presentation TVT 2019

Selective Use — Is There a Middle Ground?

Presenter: Jeffrey Moses

June 13, 2019

Presentation TVT 2019

Not Necessary — Soft Data and Excessive Costs!

Presenter: David Muller

June 13, 2019

Presentation TVT 2019

Systematic — In All Patients, Whenever Possible!

Presenter: Nicolas Van Mieghem

June 13, 2019

Presentation TVT 2019

Cerebral Embolic Protection for TAVR With TriGuard 3: Updates From the REFLECT Clinical Trial

Presenter: Tamim Nazif

June 13, 2019

Advertisement

Slides

Acute Kidney Injury After Transcatheter Aortic Valve Replacement Is a Strong Predictor of Intermediate but Not Long-Term Mortality: Observations From Michigan Transcatheter Aortic Valve Replacement (MITAVR) Registry

Feasibility of Repeat Transcatheter Aortic Valve Replacement (TAVR) After Sapien 3 TAVR (TAV-in-TAV): A Pilot Angiographic Study

Diabetes Mellitus: Is There a True Paradoxical Clinical Outcome After AVR?

Transcatheter Aortic Valve-in-Valve in Patients With Previous Homograft

Outcomes of Transcatheter Aortic Valve Replacement (TAVR) for Mixed Aortic Valve Disease: Results From the TVT Registry

Rationalizing the Cost Effectiveness of Cerebral Protection During TAVR

Selective Use — Is There a Middle Ground?

Not Necessary — Soft Data and Excessive Costs!

Systematic — In All Patients, Whenever Possible!

Cerebral Embolic Protection for TAVR With TriGuard 3: Updates From the REFLECT Clinical Trial

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content